KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Accumulated Depreciation & Amortization (2016 - 2025)

Amgen has reported Accumulated Depreciation & Amortization over the past 17 years, most recently at $5.2 billion for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 7.6% year-over-year to $5.2 billion; the TTM value through Dec 2025 reached $5.2 billion, down 7.6%, while the annual FY2025 figure was $5.2 billion, 7.6% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $5.2 billion at Amgen, down from $5.6 billion in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $5.6 billion in Q4 2024 and troughed at $3.4 billion in Q4 2021.
  • A 5-year average of $4.3 billion and a median of $4.1 billion in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 37.36% in 2024 and later decreased 7.6% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $3.4 billion in 2021, then grew by 0.56% to $3.4 billion in 2022, then increased by 19.14% to $4.1 billion in 2023, then soared by 37.36% to $5.6 billion in 2024, then decreased by 7.6% to $5.2 billion in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for AMGN at $5.2 billion in Q4 2025, $5.6 billion in Q4 2024, and $4.1 billion in Q4 2023.